Protagonist Therapeutics: Q1 Earnings Snapshot

Published: 2025-05-06 17:25:11 ET PTGX

Published on 05/06/2025 at 17:25

NEWARK, Calif. (AP) — NEWARK, Calif. (AP) — Protagonist Therapeutics Inc. (PTGX) on Tuesday reported a loss of $11.7 million in its first quarter.

On a per-share basis, the Newark, California-based company said it had a loss of 19 cents.

The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 50 cents per share.

The biopharmaceutical company posted revenue of $28.3 million in the period, also beating Street forecasts. Three analysts surveyed by Zacks expected $11.3 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PTGX at https://www.zacks.com/ap/PTGX

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News